Bacil Pharma Ltd Screener
Small Cap
With a marketcap of ₹ 28.88 Cr Stock is ranked 4012
Bacil Pharma Investment Return
Short Term
8.21 %
54.17 %
152.52 %
106.75 %
Long Term
549.54 %
545.26 %
2402.04 %
573.63 %
Bacil Pharma Return Calculator
₹
Bacil Pharma Revenue and Profit and Growth
- No Strength found.
- No Weakness found.